NCT04035551

Brief Summary

The HEALTH Registry is a prospective, observational, non-interventional registry study of patients receiving home parenteral nutrition therapy in the US for a variety of indications.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,700

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 17, 2019

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

July 9, 2019

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 29, 2019

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

June 22, 2022

Status Verified

March 1, 2022

Enrollment Period

4 years

First QC Date

July 9, 2019

Last Update Submit

June 20, 2022

Conditions

Keywords

HomeHPNHomecare

Outcome Measures

Primary Outcomes (2)

  • Change in Quality of Life over time: The Short Form (36)

    To examine the effect of HPN support on quality of life (functional health and well-being) as measured by The Short Form (36) Health Survey (SF-36v2). Physical component summary (PCS) and mental component summary (MCS) scores on a scale of 0 to 100 with higher scores reflecting better outcomes will be utilized.

    At baseline and every 6 months during therapy through study completion, up to 3 years

  • Efficacy of Home Parenteral Nutrition defined as the percentage of patients reaching their PN therapy goals

    The therapy goals (i.e. weight gain, weight loss, weight maintenance, resolution of GI issue, etc). will be recorded at study start. Percentage of patients reaching their designated therapy goal will be recorded (presented as a single percentage of patients that successful reached any therapy goal)

    through study completion, an average of 3 years

Secondary Outcomes (3)

  • Catheter-related infections

    through study completion, an average of 3 years

  • Number of hospital readmissions and ER visits

    through study completion, an average of 3 years

  • Mortality rate

    through study completion, an average of 3 years

Study Arms (1)

patients receiving home parenteral nutrition

Includes patients receiving home parenteral nutrition for any indication.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The HEALTH Registry program will collect data representative of patients receiving total parenteral nutrition (TPN) in the homecare setting.

You may qualify if:

  • Patient of any age, gender, and indication referred to Coram/CVS Specialty Infusion Services to receive HPN in an alternate site of care, such as the home or infusion suite
  • Patient must be managed by Coram/CVS Specialty Infusion Services
  • The patient or the patient's caregiver must be willing to receive care and comply with the teaching and training necessary to administer treatment

You may not qualify if:

  • Patient is unable to start, or stops receiving HPN
  • Patient is NOT managed by Coram/CVS Specialty Infusion Services
  • A patient and/or a patient's insurance will not cover cost of HPN therapy with Coram/CVS, or a patient elects not to start treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Coram CVS Specialty Infusion Services

Centennial, Colorado, 80112, United States

Location

MeSH Terms

Conditions

Malnutrition

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Mark DeLegge, MD

    Coram

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 9, 2019

First Posted

July 29, 2019

Study Start

June 17, 2019

Primary Completion

July 1, 2023

Study Completion

July 1, 2024

Last Updated

June 22, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations